Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
Journal of the National Cancer Institute.
Times cited: 14
Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.
Times cited: 7